Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Calms an overactive bladder. | Once-daily overactive bladder tablet. |
| Body system | Kidney & Bladder | Kidney & Bladder |
| Drug class | Bladder antimuscarinics | Bladder antimuscarinics |
| Supply | Prescription only | Prescription only |
| Main uses | Overactive bladder, Bedwetting in children (second line), Excessive sweating (off-label) | Overactive bladder |
| How it works | Relaxes the bladder so it holds more. | Reduces the urge to pass urine. |
| Starts working | — | — |
| Half-life | 2–5 hours | 45–68 hours |
| Typical adult dose | 2.5–5 mg two or three times a day, or 5–20 mg modified-release once a day. | 5 mg once a day, up to 10 mg. |
| Forms | Tablet, Modified-release tablet, Patch, Gel | Tablet, Oral suspension |
| Common side effects | Dry mouth, Constipation, Blurred vision, Drowsiness | Dry mouth, Constipation, Blurred vision |
| Serious side effects | Confusion in older people, Urinary retention, Overheating (reduced sweating) | Urinary retention, QT prolongation (high doses) |
| Don't take if | — | — |
| Alcohol | — | — |
| Pregnancy | Use with cautionLimited data. | Use with cautionLimited data. |
| Breastfeeding | — | — |
| In use since | 1975 | 2004 |
| Brand names | United States: Ditropan XL, OxytrolUnited Kingdom: Lyrinel XL, KenteraIndia: Oxyspas, Cystran | United States: VesicareUnited Kingdom: VesicareIndia: Soliten, Vesigard |
| Legal status | — | — |
| ATC code | G04BD04 | G04BD08 |
Taken together
- ModerateOxybutynin + Solifenacin: High anticholinergic burden
Adding anticholinergic drugs increases dry mouth, constipation, urinary retention, blurred vision and confusion — and in older people, falls and possibly dementia risk.